UV SOLID STATE DETECTION AND METHODS THEREFOR: Diagnosis of Infectious Diseases

UV SOLID STATE DETECTION AND METHODS THEREFOR

Micro Detect, Inc. ("MDI"), a medical diagnostic company located in Southern California, has recently developed an innovative diagnostic technique for conducting antigen/antibody tests. MDI has sought the protection of its innovative diagnostic technique in a published PCT patent application. MDI’s innovative diagnostic technique is a pragmatic approach to rapid antigen/antibody tests, which has an estimated worldwide market of over $60B/year. MDI’s innovative diagnostic technique is a fast, easy to use, one step, and low-cost method that delivers point of care or on-site testing. MDI’s innovative diagnostic technique may be used in the diagnosis of infectious diseases in humans and animals, and for a single or multiple analysis in one run. The diagnostic test may also be used for the detection of autoimmune disorders, cancer markers, antibodies to allergens, proteins, nucleic acids, et cetera. The diagnostic test may also be developed for the longitudinal follow-up of chronic disease-states. The specimens or test samples may include tear, saliva, blood, serum, plasma, urine, stool, or any other body discharge. MDI’s innovative diagnostic technique may also be utilized in the food industry by using extracts of food containing microorganisms or their toxins as the samples. MDI has designed and developed a prototype detection instrument, which has provided sufficient data to demonstrate feasibility. Below please find a site associated with a published article that supports the efficacy of MDI’s technology: http://file.scirp.org/pdf/IJCM_2017052614544575.pdf MDI is currently looking for a high-tech company that would like to acquire the aforementioned MDI’s technology.